Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 97

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 97
---
31, Attention: Corporate Secretary.

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

We file annual, quarterly and current reports, proxy statements and other information with the SEC. Such filings are made available on our Internet website, www.mirapharmaceuticals.com, as soon as reasonably practicable after they are filed with, or furnished to, the SEC. The information on our website is not, and shall not be deemed to be, a part of this Proxy Statement or incorporated into any other filings we make with the SEC. The SEC maintains an Internet site, www.sec.gov, which contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including the Company.

<div align='center'>INFORMATION INCORPORATED BY REFERENCE</div>

This proxy statement incorporates by reference the documents listed below that MIRA has previously filed with the SEC (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules). They contain important information about MIRA and its financial condition.

| ● 
 ● | Annual                                                                                                                      
 Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 28, 2025.                      
 Quarterly                                                                                                                   
 Report on Form 10-Q for the for the quarterly period ended March 31, 2025 filed with the SEC on May 14, 2025;               |
|:--|:----------------------------------------------------------------------------------------------------------------------------|
| ● | Current                                                                                                                     
 Reports on Form 8-K filed with the SEC on April                                                                             
 1, 2025, April                                                                                                              
 11, 2025, April                                                                                                             
 16, 2025, April                                                                                                             
 23, 2025, May                                                                                                               
 6, 2025, May                                                                                                                
 8, 2025, May                                                                                                                
 21, 2025 and May 28, 2025; and                                                                                              |
| ● | the                                                                                                                         
 description of MIRA’s common stock contained in its registration statement on Form 8-A, filed with the SEC on July 31, 2023 
 including all amendments and reports filed for the purpose of updating such description.                                    |

To the extent that any information contained in any report on Form 8-K, or any exhibit thereto, was furnished to, rather than filed with, the SEC by MIRA, such information or exhibit is specifically